Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

CD19 CAR-T Therapy for Patients with Relapsed or Refractory Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study

Jinglei Yu, Fengmei Song, Mingming Zhang, Mingfeng Zhao, Wei Sang, Songfu Jiang, Lixin Wang, Xingbing Wang, He Huang, Yongxian Hu, Guoqing Wei

Blood (2024) 144 (Supplement 1): 4201.

https://doi.org/10.1182/blood-2024-210616

Published: 2024

Journal Articles

1‰ Regular Dose of Metabolically Armored CD19 CAR-T Cells Induces Robust in vivo Expansion and Complete Remission in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

Yongxian Hu, Mingming Zhang, Shan Fu, Ruimin Hong, Jiazhen Cui, Simao Huang, Min Gao, Daojun Bai, Jingjing Ren, Xingbing Wang, Yugang Guo, Li Tang, He Huang

Blood (2024) 144 (Supplement 1): 2074.

https://doi.org/10.1182/blood-2024-207694

Published: 2024

Journal Articles

IL-10 Expressing CD19 CAR-T Cells Induce Complete Remission and Improve Long-Term Protection in Relapsed or Refractory B-Cell Hematological Malignancies

Yugang Guo, Qianwen Xu, Lei Xue, Erlin Chen, Xuhan Zhang, Chonglin Liu, Min Gao, Youjia Li, Jingjing Ren, Karthik Sathiyanadan, Li Tang, He Huang, Yongxian Hu, Xingbing Wang

Blood (2024) 144 (Supplement 1): 92.

https://doi.org/10.1182/blood-2024-206439

Published: 2024

Journal Articles

Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL

Yongxian HU, Guoqing Wei, Shan Fu, Pingnan Xiao, Jingjing Feng, Mingming Zhang, Xingbing Wang, Dongrui Wang, Jun Li, He Huang

Blood (2023) 142 (Supplement 1): 2111.

https://doi.org/10.1182/blood-2023-189052

Published: 2023

Journal Articles

Automation Platform for CAR-T Manufacturing: The Benefits and the Clinical Outcomes

Min Wang, PhD, Fengtao You, PhD, Xingbing Wang, MD, Bingzong Li, MD PhD, Hanying Xu, MS, Yu Wang, MS, Guifang Pan, MS, Song Sun, MS, Huimin Meng, MD PhD, Yanmei Zhao, MS, Yu-Sheng Chen, PhD, Bozhen Zhang, MBA, Lin Yang, PhD

Blood (2019) 134 (Supplement_1): 1960.

https://doi.org/10.1182/blood-2019-123656

Published: 2019

Journal Articles

Prospective Cohort Study Comparing Intravenous Busulfan Versus Total Body Irradiation in Cord Blood Transplantation

Blood (2018) 132 (Supplement 1): 5709.

https://doi.org/10.1182/blood-2018-99-118681

Published: 2018

Journal Articles

The Embt Risk Score Predicts the Outcome of Patients with Leukaemia Receiving Single Umbilical Cord Blood Transplantation

Xiaoyu Zhu, Baolin Tang, Changcheng Zheng, PhD, Huilan Liu, Liangquan Geng, Juan Tong, MD, Lei Zhang, Xuhan Zhang, Wen Yao, Kaidi Song, Xingbing Wang, MD, Kaiyang Ding, PhD, Zimin Sun, MD

Blood (2016) 128 (22): 2275.

https://doi.org/10.1182/blood.V128.22.2275.2275

Published: 2016

Journal Articles

Intensified Myeloablative Unrelated Cord Blood Transplantation for High-Risk or Advanced Hematological Malignancies: Experience at a Single-Institution in China

Zimin Sun, Huilan Liu, Baolin Tang, Xiaoyu Zhu, Wen Yao, Juan Tong, MD, Kaidi Song, Liangquan Geng, Xingbing Wang, PhD MD, Kaiyang Ding, PhD, Changcheng Zheng, MD, Weibo Zhu

Blood (2014) 124 (21): 1222.

https://doi.org/10.1182/blood.V124.21.1222.1222

Published: 2014

Journal Articles

Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy

Xingbing Wang, PhD MD, Stephen Gottschalk, MD, Xiao-Tong Song, PhD

Blood (2014) 124 (21): 5808.

https://doi.org/10.1182/blood.V124.21.5808.5808

Published: 2014

Journal Articles

Pre-Engraftment Syndrome After Myeloablative Umbilical Cord Blood Transplantation: Risk Factors and How To Stratify

Zimin Sun, MD, Maojing Guan, MD, Huilan Liu, MD, Liangquan Geng, MD, Xingbing Wang, PhD, MD, Changcheng Zheng, MD, Juan Tong, MD, Baolin Tang, MD, Wen Yao, MD

Blood (2013) 122 (21): 5482.

https://doi.org/10.1182/blood.V122.21.5482.5482

Published: 2013

Journal Articles

Outcomes of Unrelated Umbilical Cord Blood Transplantation Using a Conditioning Regimen of TBI/Ara-c/CY without ATG for Adolescent and Adults Patients with High-Risk Hematologic Malignancies

Zimin Sun, MD, Huilan Liu, MD, Liangquan Geng, MD, Xingbing Wang, PhD, MD, Kaiyang Ding, PhD, MD, Juan Tong, MD, Baolin Tang, MD, Chenyang Zhou, MD, Wen Yao, MD, Yun Wu, Changcheng Zheng, MD, Xin Liu, MD, Weibo Zhu, MD, Zhuyi Wang, MD

Blood (2012) 120 (21): 4525.

https://doi.org/10.1182/blood.V120.21.4525.4525

Published: 2012

Journal Articles

Similar Survival, but Better Quality of Life After Myeloablative Transplantation Using Unrelated Cord Blood Versus Identical Sibling Hematopoietic Cells in Adults with Hematologic Malignancies: A Single Institute Analysis.

Huilan Liu, MD, Liangquan Geng, MD, Xingbing Wang, PhD, MD, Kaiyang Ding, PhD, MD, Juan Tong, MD, Baolin Tang, MD, Chenyang Zhou, MD, Yun Wu, Wen Yao, MD, Changcheng Zheng, MD, Xin Liu, MD, Weibo Zhu, MD, Zhuyi Wang, MD, Zimin Sun, MD

Blood (2012) 120 (21): 3134.

https://doi.org/10.1182/blood.V120.21.3134.3134

Published: 2012

Journal Articles

Unrelated Umbilical Cord Blood Transplantation for Hematological Malignancies Using Fludarabine/BUCY2 Conditioning Regimen

Zimin Sun, Huilan Liu, Liangquan Geng, MD, Xingbing Wang, PhD, MD, Kaiyang Ding, PhD, MD, Yun Wu, Chenyang Zhou, Juan Tong, Kaidi Song, Hongjun Liu, Chun Li, Zuyi Wang

Blood (2011) 118 (21): 4572.

https://doi.org/10.1182/blood.V118.21.4572.4572

Published: 2011

Journal Articles

Comparative Analysis of Single-Institute Transplantation From Unrelated Cord Blood and Related Adult Donors In Adults with Hematologic Malignancies.

Zimin Sun, MD, Huilan Liu, MD, Liangquan Geng, MD, Xingbing Wang, PhD, MD, Kaiyang Ding, PhD, MD, Chengyang Zhou, Baolin Tang, MD, Juan Tong, MD, Wen Yao, MD, Zuyi Wang, MD

Blood (2010) 116 (21): 4570.

https://doi.org/10.1182/blood.V116.21.4570.4570

Published: 2010

Journal Articles

Irradiation-Based Myeloablative Cord Blood Transplantation for Hematologic Malignancies In Adults.

Huilan Liu, Xingbing Wang, PhD, MD, Liangquan Geng, Kaiyang Ding, PhD, MD, Baolin Tang, Juan Tong, Wen Yao, Zuyi Wang, Zimin Sun

Blood (2010) 116 (21): 4583.

https://doi.org/10.1182/blood.V116.21.4583.4583

Published: 2010

Journal Articles

Glycosylation Engineering Combined with CD26 Inhibitor Enhances Umbilical Blood Cells Engraftment In the NOD/SCID Mouse

Zimin Sun, Chengyang Zhou, Xingbing Wang, PhD, MD, Jian Wang, Huilan Liu, Fupeng Ren, Kaiyang Ding, PhD, MD

Blood (2010) 116 (21): 4687.

https://doi.org/10.1182/blood.V116.21.4687.4687

Published: 2010

Journal Articles

Toll-Like Receptors 2 and 4 Mediate the Capacity of Human Bone Marrow-Derived Mesenchymal Stem Cells to Support the Proliferation and Differentiation of CD34 + Cells In a Non-Synergistic Way.

Xingbing Wang, PhD, MD, Qiansong Cheng, Jian Wang, Liang Xia, Xuhan Zhang, Kaiyang Ding, PhD, MD, Zimin Sun

Blood (2010) 116 (21): 3850.

https://doi.org/10.1182/blood.V116.21.3850.3850

Published: 2010

Journal Articles

Pre-Engraftment Syndrome Following Umbilical Cord Blood Transplantation Is a Strong Predictor of Acute Graft-Versus-Host Disease

Xingbing Wang, PhD, MD, Zimin Sun, Huilan Liu, Liangquan Geng, Kaiyang Ding, PhD, MD, Weibo Zhu, Zuyi Wang

Blood (2010) 116 (21): 1267.

https://doi.org/10.1182/blood.V116.21.1267.1267

Published: 2010

Journal Articles

Unrelated Cord Blood Transplantation for Severe Acquired Aplastic Anemia Using a Reduced-Intensity Conditioning: High Graft Rejection but Good Survival

Huilan Liu, Liangquan Geng, Xingbing Wang, PhD, MD, Kaiyang Ding, PhD, MD, Baolin Tang, Juan Tong, Wen Yao, Zuyi Wang, Zimin Sun

Blood (2010) 116 (21): 2368.

https://doi.org/10.1182/blood.V116.21.2368.2368

Published: 2010

Journal Articles

Outcome of Umbilical Cord Blood Transplantation in 51 Patients with Hematologic Malignancies.

Zimin Sun, Huilan Liu, Liangquan Geng, Xingbing Wang, Xinchen Fang, Xin Liu, Huizhi Yang, Yongsheng Han, Weibo Zhu, Zuyi Wang

Blood (2009) 114 (22): 4342.

https://doi.org/10.1182/blood.V114.22.4342.4342

Published: 2009

NARROW

CD19 CAR-T Therapy for Patients with Relapsed or Refractory Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study

1‰ Regular Dose of Metabolically Armored CD19 CAR-T Cells Induces Robust in vivo Expansion and Complete Remission in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

IL-10 Expressing CD19 CAR-T Cells Induce Complete Remission and Improve Long-Term Protection in Relapsed or Refractory B-Cell Hematological Malignancies

Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL

Automation Platform for CAR-T Manufacturing: The Benefits and the Clinical Outcomes

Prospective Cohort Study Comparing Intravenous Busulfan Versus Total Body Irradiation in Cord Blood Transplantation

The Embt Risk Score Predicts the Outcome of Patients with Leukaemia Receiving Single Umbilical Cord Blood Transplantation

Intensified Myeloablative Unrelated Cord Blood Transplantation for High-Risk or Advanced Hematological Malignancies: Experience at a Single-Institution in China

Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy

Pre-Engraftment Syndrome After Myeloablative Umbilical Cord Blood Transplantation: Risk Factors and How To Stratify

Outcomes of Unrelated Umbilical Cord Blood Transplantation Using a Conditioning Regimen of TBI/Ara-c/CY without ATG for Adolescent and Adults Patients with High-Risk Hematologic Malignancies

Similar Survival, but Better Quality of Life After Myeloablative Transplantation Using Unrelated Cord Blood Versus Identical Sibling Hematopoietic Cells in Adults with Hematologic Malignancies: A Single Institute Analysis.

Unrelated Umbilical Cord Blood Transplantation for Hematological Malignancies Using Fludarabine/BUCY2 Conditioning Regimen

Comparative Analysis of Single-Institute Transplantation From Unrelated Cord Blood and Related Adult Donors In Adults with Hematologic Malignancies.

Irradiation-Based Myeloablative Cord Blood Transplantation for Hematologic Malignancies In Adults.

Glycosylation Engineering Combined with CD26 Inhibitor Enhances Umbilical Blood Cells Engraftment In the NOD/SCID Mouse

Toll-Like Receptors 2 and 4 Mediate the Capacity of Human Bone Marrow-Derived Mesenchymal Stem Cells to Support the Proliferation and Differentiation of CD34 + Cells In a Non-Synergistic Way.

Pre-Engraftment Syndrome Following Umbilical Cord Blood Transplantation Is a Strong Predictor of Acute Graft-Versus-Host Disease

Unrelated Cord Blood Transplantation for Severe Acquired Aplastic Anemia Using a Reduced-Intensity Conditioning: High Graft Rejection but Good Survival

Outcome of Umbilical Cord Blood Transplantation in 51 Patients with Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only